pLKO-shp38 Citations (9)

Originally described in: p38MAPK plays a crucial role in stromal mediated tumorigenesis.
Alspach E, Flanagan KC, Luo X, Ruhland MK, Huang H, Pazolli E, Donlin MJ, Marsh T, Piwnica-Worms D, Monahan J, Novack DV, McAllister SS, Stewart SA Cancer Discov. 2014 Mar 26. PubMed Journal

---

Articles Citing pLKO-shp38

Articles
Extracellular vesicles enhance oxidative stress through P38/NF-kB pathway in ketamine-induced ulcerative cystitis. Xi XJ, Zeng JJ, Lu Y, Chen SH, Jiang ZW, He PJ, Mi H. J Cell Mol Med. 2020 May 22. doi: 10.1111/jcmm.15397. PubMed
Deregulation of Exo70 Facilitates Innate and Acquired Cisplatin Resistance in Epithelial Ovarian Cancer by Promoting Cisplatin Efflux. Zhao Y, Hong X, Chen X, Hu C, Lu W, Xie B, Zhong L, Zhang W, Cao H, Chen B, Liu Q, Zhan Y, Xiao L, Hu T. Cancers (Basel). 2021 Jul 11;13(14):3467. doi: 10.3390/cancers13143467. PubMed
Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer. Ruiz-Fernandez de Cordoba B, Moreno H, Valencia K, Perurena N, Ruedas P, Walle T, Pezonaga-Torres A, Hinojosa J, Guruceaga E, Pineda-Lucena A, Abengozar-Muela M, Cochonneau D, Zandueta C, Martinez-Canarias S, Teijeira A, Ajona D, Ortiz-Espinosa S, Morales X, Ortiz de Solorzano C, Santisteban M, Ramos-Garcia LI, Guembe L, Strnad V, Heymann D, Hervas-Stubbs S, Pio R, Rodriguez-Ruiz ME, de Andrea CE, Vicent S, Melero I, Lecanda F, Martinez-Monge R. Cancer Discov. 2022 May 2;12(5):1356-1377. doi: 10.1158/2159-8290.CD-21-0932. PubMed
miRNA-34c Suppresses Osteosarcoma Progression In Vivo by Targeting Notch and E2F. Bae Y, Zeng HC, Chen YT, Ketkar S, Munivez E, Yu Z, Gannon FH, Lee BH. JBMR Plus. 2022 Apr 9;6(5):e10623. doi: 10.1002/jbm4.10623. eCollection 2022 May. PubMed
LRIG2 promotes glioblastoma progression by modulating innate antitumor immunity through macrophage infiltration and polarization. Hu J, Dong F, He Y, Xia X, Cheng F, Chen S, Hou X, Zhang P, Liu G, Li Y, Gao Q, Dong M, Li T, Li W, Xiao Q, Li X, Yu X, Xi G, Guo D, Wu X, Wang B. J Immunother Cancer. 2022 Sep;10(9):e004452. doi: 10.1136/jitc-2021-004452. PubMed
Exo70 Promotes the Invasion of Pancreatic Cancer Cells via the Regulation of Exosomes. Xiang J, Zheng B, Zhao L, He Y, Lou F, Li R, Fu M, Huang X, Zhang W, Hong X, Xiao L, Hu T. Cancers (Basel). 2024 Jan 12;16(2):336. doi: 10.3390/cancers16020336. PubMed
Mitochondrial uncouplers inhibit oncogenic E2F1 activity and prostate cancer growth. Hawsawi O, Xue W, Du T, Guo M, Yu X, Zhang M, Hoffman PS, Bollag R, Li J, Zhou J, Wang H, Zhang J, Fu Z, Chen X, Yan C. Cell Rep Med. 2025 Jan 21;6(1):101890. doi: 10.1016/j.xcrm.2024.101890. Epub 2025 Jan 9. PubMed
Dual ENPP1/ATM depletion blunts DNA damage repair boosting radioimmune efficacy to abrogate triple-negative breast cancer. Ruiz-Fernandez de Cordoba B, Valencia K, Welch C, Moreno H, Martinez-Canarias S, Zandueta C, Gomez E, Calvo A, Otegui N, Echepare M, Garzon I, Ajona D, Lara-Astiaso D, Guruceaga E, Guembe L, Pio R, Melero I, Vicent S, Pastor F, Martinez-Monge R, Lecanda F. Signal Transduct Target Ther. 2025 Jun 13;10(1):185. doi: 10.1038/s41392-025-02271-2. PubMed
Lysine methylation-mediated SMYD2 degradation by casticin sensitizes non-small-cell lung cancer cells to osimertinib therapy. Pan K, Xu B, Lou Y, Xue J, Jin X, Dang M, Pan S, Huang Z, Chen X. Biochem Pharmacol. 2026 Jan;243(Pt 2):117562. doi: 10.1016/j.bcp.2025.117562. Epub 2025 Nov 26. PubMed

If you have published an article using this material, please email us at to have your article added to this page.